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Abstract 
Background: In large health care systems, decision regarding broad implementation of psychotherapies for inpa‑
tients with psychosis require substantial evidence regarding effectiveness and feasibility for implementation. It is 
important to recognize challenges in conducting research to inform such decisions, including difficulties in obtaining 
consent from and engaging inpatients with psychosis in research. We set out to conduct a feasibility and effectiveness 
Hybrid Type I pilot randomized controlled trial of acceptance and commitment therapy (ACT) and a semi‑formative 
evaluation of barriers and facilitators to implementation.
Findings: We developed a training protocol and refined an ACT treatment manual for inpatient treatment of psycho‑
sis for use at the Veterans Health Administration. While our findings on feasibility were mixed, we obtained support‑
ive evidence of the acceptability and safety of ACT. Identified strengths of ACT included a focus on achievement of 
valued goals rather than symptoms. Weaknesses included that symptoms may limit patient’s understanding of ACT. 
Facilitators included building trust and multi‑stage informed consent processes. Barriers included restrictive eligibility 
criteria, rigid use of a manualized protocol, and individual therapy format. Conclusions are limited by our randomiza‑
tion of only 18 patient participants (with nine completing all aspects of the study) out of 80 planned.
Conclusions: Future studies should include (1) multi‑stage informed consent processes to build trust and alleviate 
patient fears, (2) relaxation of restrictions associated with obtaining efficacy/effectiveness data, and (3) use of Hybrid 
Type II and III designs.
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Background
Psychotic disorders, which include schizophrenia, schiz-
oaffective disorder, and bipolar disorder with psycho-
sis, are complex and often chronic conditions. Health 
systems seek to deliver ongoing outpatient care to help 
patients maintain function and symptom stability. How-
ever, this is difficult due to periodic exacerbations [5], low 
tolerance of normative stressors [17], and disengagement 
from mental health treatment [15]. Indeed, patients with 
psychotic disorders receive substantial and costly inpa-
tient treatment [4, 13]. To help patients achieve stability 
and return to the community, recommended inpatient 
treatments include a mix of medication, psychotherapy, 
and engagement with other patients and staff [7]. Unfor-
tunately, patients with psychosis are often readmitted to 
inpatient units, suggesting the need for recovery-focused 
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Empirically supported psychotherapies such as accept-
ance and commitment therapy (ACT) are more recov-
ery-oriented than symptom-focused [11]. ACT utilizes 
mindfulness and acceptance strategies to increase 
patients’ abilities to cope with symptoms and dysfunction 
[11]. Two randomized controlled trials (RCTs) have dem-
onstrated the effectiveness of ACT relative to usual care: 
Patients receiving ACT demonstrate greater improve-
ments in symptoms and coping, and reduced re-hospital-
ization rates post-treatment [3, 9].
Broad implementation of treatment for inpatients 
with psychosis, and specifically of psychotherapies such 
as ACT, typically requires substantial evidence regard-
ing effectiveness and feasibility of implementation. Such 
evidence is typically garnered from research studies. This 
is especially true within large health care systems, such 
as the Veterans Health Administration (VHA). The two 
prior RCTs demonstrating the effectiveness of ACT were 
conducted in non-VHA settings. Yet, unique character-
istics (e.g., structure, patients served) of large health care 
systems, such as the VHA may influence implementation 
and effectiveness of ACT. Thus, it is important to rec-
ognize challenges involved in the process of developing 
such information. Notably, it is difficult to obtain con-
sent and engage psychiatric inpatients with psychosis in 
research (e.g., [14]).
We set out to conduct a feasibility/effectiveness Hybrid 
Type I study [6] incorporating a pilot RCT of ACT and 
a semi-formative evaluation of barriers and facilitators to 
future implementation of ACT for inpatients diagnosed 
with psychosis. Thus, we focused on obtaining data 
regarding feasibility and implementation of ACT with 
this patient population, and secondarily gaining prelimi-
nary information regarding ACT’s effectiveness (reported 
at ClinicalTrials.gov: NCT01981356). Our focus was con-
sistent with the stage model by the National Institutes 
of Health [16] and with critiques of the stage model that 
emphasize expediency early in the treatment develop-
ment process [6].
The study had two primary aims: (1) to assess whether 
ACT demonstrates feasibility, acceptability, and safety 
within the VHA inpatient setting, and (2) to obtain data 
from inpatient unit staff regarding system-, clinician-, 
and patient-level barriers and facilitators to providing 
and implementing ACT among veterans with psychosis, 
as guided by the reach, effectiveness, adoption, imple-
mentation, maintenance (RE-AIM ) framework [10].
Methods
Participants
We recruited two sets of participants: (1) 29 VHA inpa-
tients with current or recent (within past week) psy-
chotic symptoms (hallucinations and/or delusions) 
related to a DSM-IV-R [1] diagnosed psychotic or mood 
(but not substance use) disorder, and (2) four inpatient 
psychiatry unit staff members. Study or inpatient unit 
staff approached patient participants, briefly described 
the study, and elicited interest. Likewise, study staff 
approached inpatient unit staff.
Treatments
We randomly assigned patient participants to either 
treatment as usual (TAU) plus four individual sessions 
of ACT (adapted from [9]), or TAU during their entire 
length of stay (M = 18.4, SD = 13.1), with the addition of 
four sessions to equate for staff time and attention.
Measures
Patients
We collected data from patients immediately prior to 
treatment initiation and immediately prior to discharge.
Measures of feasibility, acceptability, and safety 
included: (a) the ability to recruit and consent two eligible 
patient participants per week (for 40 weeks) to be rand-
omized to TAU+ACT or TAU; (b) patient attendance at 
three out of four ACT sessions, on average; (c) patient 
and therapist reported treatment satisfaction (adapted 
Client Satisfaction Questionnaire-8; [2]) and therapeutic 
alliance (Working Alliance Inventory; [12]); and (d) the 
occurrence of zero serious adverse events.
Staff
We conducted 30–60  min semi-structured interviews 
using the RE-AIM (reach, efficacy, adoption, implementa-
tion and maintenance) framework [10] and the RE-AIM 
Planning Tool [8] to identify barriers and facilitators to 
patient participation in ACT and implementation of ACT, 
broadly, and how to address them, and perceptions about 
ACT effectiveness in achieving desired outcomes. We 
coded interviews as guided by the rapid analysis method-
ology of Curran et al. [6].
Findings
Aim 1
Findings regarding feasibility and acceptability of ACT 
were mixed. We fell short of meeting our initial goal of 
recruiting and randomizing two eligible participants per 
week for a total of 80 participants. We reviewed charts 
for 429 admission patients over 8 months; we approached 
67 patients who potentially met study criteria. Twenty-
nine patients provided informed consent and agreed to 
a comprehensive assessment for eligibility, yielding 18 
eligible participants (all were male, average age was 53.4 
(SD  =  17.5), 38.5  % were Caucasian, 30.8  % were His-
panic/Latino, 23.1  % were Black/African–American, 
and 7.7  % were Asian/Asian–American). Twelve were 
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randomized to ACT+TAU and six to TAU; however data 
could not be utilized for two participants (one signed an 
invalid consent and another was on a legal hold when 
consented). One additional participant in each condi-
tion withdrew, and five participants did not complete the 
post-treatment assessment due to discharging themselves 
or being discharged early and without notice, leaving nine 
participants (ACT+TAU = 5; TAU = 4) who completed 
all aspects of the study. We enrolled four of six planned 
inpatient psychiatry unit staff (one nursing assistant, one 
nurse, two psychologists, 75 % were male) to assess barri-
ers and facilitators.
For those receiving treatment, we successfully met our 
aims related to treatment acceptability, and safety. Intent-
to-treat participants assigned to ACT+TAU attended 
2.8 sessions on average (SD = 1.6), with five completing 
all four sessions. Participants completing ACT+TAU 
reported moderate-to-high levels of ACT satisfaction 
(M  =  2.9 of 4, SD  =  0.3) and alliance (M  =  4.7 of 7, 
SD = 1.0). ACT+TAU was safe, as indicated by no seri-
ous adverse events.
Aim 2
Staff members were consistent in their reports of (a) 
strengths of ACT (patient with chronic and pervasive 
psychosis benefit from focus on achievement of valued 
goals rather than symptom reduction); (b) weaknesses of 
ACT (symptoms [e.g., paranoia] and related sequela [e.g., 
cognitive impairment] may limit patients’ understanding 
of ACT); (c) facilitators to implementation (build trust 
with patients before treatment, offer ACT in group for-
mat; be flexible in application of manual; engage in more 
experiential or “hands-on” exercises; utilize a team-based 
approach to applying ACT); and (d) barriers to patient 
participation and implementation (difficult to obtain sup-
porting research evidence due to restrictive eligibility cri-
teria, rigid application of manualized treatment, patients’ 
limited time and motivation given their many activities 
and appointments).
Discussion
We encountered important challenges related to con-
ducting research and implementing psychotherapy on 
acute psychiatry inpatient units. The most notable chal-
lenge concerned patient recruitment. Indeed, our recruit-
ment and randomization of 18 patient participants, with 
only nine participants completing all aspects of the study, 
substantially limited our ability to draw conclusions 
regarding ACT. Identified as a weakness of ACT and 
barrier to implementation in our qualitative interviews, 
patient characteristics may have hindered recruitment 
and engagement in ACT [15]. Additionally, numerous 
patients we approached were involuntarily committed 
and conserved and thus ineligible to provide informed 
consent. Others were unwilling to provide consent, or 
provided consent and later withdrew or were discharged, 
often without notice. These issues reflect inherent diffi-
culties in conducting research with psychiatry inpatients 
[14].
For future studies, we recommend use of a multi-stage 
informed consent processes to build trust and alleviate 
patients’ potential fears. We identified building trust 
as a potential facilitator to implementation that may 
increase enrollment and enhance the therapeutic pro-
cess itself. However, we noted the difficulty of build-
ing trust when conducting a psychotherapy RCT on 
an inpatient unit, as time constraints limit interactions 
with patients. For example, the informed consent pro-
cess, pre- and post-treatment assessments, and four 
treatment sessions for our proposed trial needed to take 
place within a given patient’s relatively short inpatient 
stay. Thus, the informed consent/building of trust pro-
cess might supplant some of the therapy itself. In VHA 
settings, treatment could potentially continue post-dis-
charge, since electronic medical records allow for track-
ing of patients.
Aspects of the treatment and its implementation pre-
sented further challenges to conducting the trial. Restric-
tive eligibility criteria (e.g., excluding patients with 
substance-induced psychosis) and rigid application of 
a manualized protocol, which are normative for RCTs, 
emerged as barriers to implementation of ACT within 
VHA acute psychiatry units. A further perceived bar-
rier was the individual therapy format, which was used in 
previous ACT RCTs [3, 9].
Relaxing restrictions (e.g., flexible application of the 
manual) while tailoring the intervention (e.g., offer group 
format, facilitate buy-in by inpatient staff to engage 
patients in an ACT-consistent manner) may increase 
the ability for future studies to build an evidence base 
to inform decisions regarding broader implementation. 
While this approach is often promoted in effectiveness 
trials, it appears similarly important for preliminary stud-
ies of psychotherapy on an inpatient unit. It may prove 
expeditious to utilize Hybrid Type II or III trials that 
emphasize implementation-related outcomes more than 
patient-related outcomes [6].
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